Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Medigene AG < Previous 1 2 Next > Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China July 03, 2024 From Medigene AG Via GlobeNewswire Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness June 27, 2024 From Medigene AG Via GlobeNewswire Medigene Reports Results of Annual General Meeting June 24, 2024 From Medigene AG Via GlobeNewswire Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024 June 21, 2024 From Medigene AG Via GlobeNewswire Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors June 20, 2024 From Medigene AG Via GlobeNewswire Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office May 28, 2024 From Medigene AG Via GlobeNewswire Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term May 21, 2024 From Medigene AG Via GlobeNewswire Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS May 15, 2024 From Medigene AG Via GlobeNewswire Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise May 14, 2024 From Medigene AG Via GlobeNewswire Medigene to Present at Upcoming Conferences May 07, 2024 From Medigene AG Via GlobeNewswire Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor May 02, 2024 From Medigene AG Via GlobeNewswire Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein May 02, 2024 From Medigene AG Via GlobeNewswire Medigene presents streamlined 6-day, high stemness TCR-T therapy production process April 25, 2024 From Medigene AG Via GlobeNewswire Medigene to Present at Upcoming Scientific Conferences April 17, 2024 From Medigene AG Via GlobeNewswire Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024 April 08, 2024 From Medigene AG Via GlobeNewswire Medigene AG Secures European Patent for its iM-TCR Technology April 04, 2024 From Medigene AG Via GlobeNewswire Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update March 28, 2024 From Medigene AG Via GlobeNewswire Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference March 19, 2024 From Medigene AG Via GlobeNewswire Medigene AG to report full year 2023 financial results on March 28, 2024 March 18, 2024 From Medigene AG Via GlobeNewswire Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting March 06, 2024 From Medigene AG Via GlobeNewswire Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo March 04, 2024 From Medigene AG Via GlobeNewswire Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies February 29, 2024 From Medigene AG Via GlobeNewswire Medigene to Present at Upcoming Conferences February 19, 2024 From Medigene AG Via GlobeNewswire Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumors February 12, 2024 From Medigene AG Via GlobeNewswire Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference December 19, 2023 From Medigene AG Via GlobeNewswire Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cash Runway November 21, 2023 From Medigene AG Via GlobeNewswire Medigene amends 2023 financial guidance November 21, 2023 From Medigene AG Via GlobeNewswire Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A*11 November 04, 2023 From Medigene AG Via GlobeNewswire Medigene Reports Financial Results and Corporate Update for Q3 2023 October 26, 2023 From Medigene AG Via GlobeNewswire Medigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with a PD1-41BB costimulatory switch protein showing enhanced and sustained tumor killing October 23, 2023 From Medigene AG Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.